Is OrganiGram Holdings Stock a Good Investment?
OrganiGram Holdings Investment Advice | OGI |
- Examine OrganiGram Holdings' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research OrganiGram Holdings' leadership team and their track record. Good management can help OrganiGram Holdings navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact OrganiGram Holdings' business and its evolving consumer preferences.
- Compare OrganiGram Holdings' performance and market position to its competitors. Analyze how OrganiGram Holdings is positioned in terms of product offerings, innovation, and market share.
- Check if OrganiGram Holdings pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about OrganiGram Holdings' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in OrganiGram Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if OrganiGram Holdings is a good investment.
Sell | Buy |
Buy
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine OrganiGram Holdings Stock
Researching OrganiGram Holdings' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 28.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. OrganiGram Holdings recorded a loss per share of 0.34. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 7th of July 2023.
To determine if OrganiGram Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OrganiGram Holdings' research are outlined below:
| OrganiGram Holdings generated a negative expected return over the last 90 days | |
| OrganiGram Holdings may become a speculative penny stock | |
| OrganiGram Holdings has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 159.84 M. Reported Net Loss for the year was (45.44 M) with profit before taxes, overhead, and interest of 54.64 M. | |
| About 28.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: OrganiGram Holdings Inc Q1 2025 Earnings Call Highlights Strong Revenue Growth Amidst ... |
OrganiGram Holdings Quarterly Cost Of Revenue |
|
OrganiGram Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in OrganiGram Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OrganiGram Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 1st of February 2024 Upcoming Quarterly Report | View | |
| 9th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 17th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact OrganiGram Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises OrganiGram Holdings' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-04-12 | 2022-03-31 | -0.03 | -0.01 | 0.02 | 66 | ||
2021-11-23 | 2021-09-30 | -0.06 | -0.09 | -0.03 | 50 | ||
2021-07-13 | 2021-06-30 | -0.04 | -0.01 | 0.03 | 75 | ||
2024-02-13 | 2023-12-31 | -0.105 | -0.1425 | -0.0375 | 35 | ||
2023-01-22 | 2022-12-31 | -0.02 | 0.02 | 0.04 | 200 | ||
2019-04-15 | 2019-03-31 | 0.01 | -0.04 | -0.05 | 500 | ||
2024-09-30 | 2024-09-30 | -0.035 | -0.1012 | -0.0662 | 189 | ||
2022-07-14 | 2022-06-30 | -0.02 | -0.09 | -0.07 | 350 |
Know OrganiGram Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OrganiGram Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OrganiGram Holdings backward and forwards among themselves. OrganiGram Holdings' institutional investor refers to the entity that pools money to purchase OrganiGram Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goldman Sachs Group Inc | 2024-09-30 | 147.1 K | Two Sigma Advisers, Llc | 2024-09-30 | 125.8 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 71.2 K | Graham Capital Management | 2024-09-30 | 45.4 K | Clear Harbor Asset Management, Llc | 2024-12-31 | 45 K | Jane Street Group Llc | 2024-09-30 | 42.3 K | Bank Of America Corp | 2024-09-30 | 36.4 K | Group One Trading, Lp | 2024-09-30 | 35.4 K | Vontobel Holding Ltd. | 2024-12-31 | 29 K | Tidal Investments Llc. | 2024-09-30 | 1.9 M | Millennium Management Llc | 2024-09-30 | 1.3 M |
OrganiGram Holdings' market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 160.95 M.OrganiGram Holdings' profitablity analysis
The company has Net Profit Margin of (0.32) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.16) %, which entails that for every $100 of revenue, it lost $0.16.Determining OrganiGram Holdings' profitability involves analyzing its financial statements and using various financial metrics to determine if OrganiGram Holdings is a good buy. For example, gross profit margin measures OrganiGram Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OrganiGram Holdings' profitability and make more informed investment decisions.
Evaluate OrganiGram Holdings' management efficiency
OrganiGram Holdings has Return on Asset of (0.0556) % which means that on every $100 spent on assets, it lost $0.0556. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5453) %, meaning that it generated no profit with money invested by stockholders. OrganiGram Holdings' management efficiency ratios could be used to measure how well OrganiGram Holdings manages its routine affairs as well as how well it operates its assets and liabilities.At OrganiGram Holdings, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Beta 1.044 |
Basic technical analysis of OrganiGram Stock
As of the 16th of February 2025, OrganiGram Holdings holds the Risk Adjusted Performance of (0.04), coefficient of variation of (1,563), and Variance of 15.48. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OrganiGram Holdings, as well as the relationship between them.OrganiGram Holdings' Outstanding Corporate Bonds
OrganiGram Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OrganiGram Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OrganiGram bonds can be classified according to their maturity, which is the date when OrganiGram Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand OrganiGram Holdings' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing OrganiGram Holdings' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (1.16) | |||
| Mean Deviation | 2.81 | |||
| Coefficient Of Variation | (1,563) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.48 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (1.17) | |||
| Maximum Drawdown | 27.11 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 5.23 | |||
| Skewness | (0.93) | |||
| Kurtosis | 4.34 |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (1.16) | |||
| Mean Deviation | 2.81 | |||
| Coefficient Of Variation | (1,563) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.48 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (1.17) | |||
| Maximum Drawdown | 27.11 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 5.23 | |||
| Skewness | (0.93) | |||
| Kurtosis | 4.34 |
Consider OrganiGram Holdings' intraday indicators
OrganiGram Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OrganiGram Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OrganiGram Holdings time-series forecasting models is one of many OrganiGram Holdings' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OrganiGram Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
OrganiGram Stock media impact
Far too much social signal, news, headlines, and media speculation about OrganiGram Holdings that are available to investors today. That information is available publicly through OrganiGram media outlets and privately through word of mouth or via OrganiGram internal channels. However, regardless of the origin, that massive amount of OrganiGram data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OrganiGram Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OrganiGram Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OrganiGram Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OrganiGram Holdings alpha.
OrganiGram Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards OrganiGram Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
OrganiGram Holdings Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Helen Martin | Chief Secretary | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Megan McCrae | Senior Communications | Profile | |
| Amy Schwalm | VP Relations | Profile | |
| CFA CA | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share 1.606 | Quarterly Revenue Growth 0.172 | Return On Assets (0.06) | Return On Equity |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between OrganiGram Holdings' value and its price, as these two are different measures arrived at by various means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.